Randeep S Bajwa, MD
Nephrology · Stockton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 27 years
- Graduated 1999
Offices
1 location
Looking this up.
Hospitals listed: 052723 · 552577 · 552606 · 552632 · 552704 · Doctors Hospital of Manteca · Memorial Medical Center · St Joseph'S Medical Center of Stockton · Sutter Amador Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bajwa’s office at (209) 888-4340 to ask if they take your plan before you enroll.
California Medical Board record
Licence A104576 · Current
Licensed to practise in California · since 2008 · expires 2028-01-31 · Guru Nanak Dev University Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Doctors Hospital of MantecaManteca, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency departmentPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 55% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.165, Oct 2024 – Sep 2025
- Memorial Medical CenterModesto, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.093, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.085, Oct 2024 – Sep 2025
- St Joseph'S Medical Center of StocktonStockton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 67% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.08, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.34, Oct 2024 – Sep 2025
- Sutter Amador HospitalJackson, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Doctors Hospital of Manteca
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 4 the same, 2 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.165 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.09) · 230 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.49 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 30 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.5 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 700 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.33 (0.1 to 0.56) · 1,428 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,462 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.24 to 6.39) · 137 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.28 (0.57 to 4) · 130 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.23 to 3.28) · 58 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,152 cases | No different | Jul 2022 – Jun 2024 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.4 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 67.3 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 60 · 183 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.4 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 48 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.2 to 16.8) · 379 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 52 cases | No different | Jan 2024 – Dec 2024 |
What patients said (339 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 1 |
| Doctor communication | 1 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 68% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 77% |
| Doctors "always" explained things so they could understand | 62% |
| Doctors "always" listened carefully | 65% |
| Doctors "always" treated them with courtesy and respect | 76% |
| Patients who gave a rating of "9" or "10" (high) | 56% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 62% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 55% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Memorial Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.093 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.085 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.41 to 2.2) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.75 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.77 (144.66 to 226.88) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.2 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.1 · 194 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.9 · 513 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 640 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 4,882 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.42) · 10,183 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 10,422 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.4 (1.58 to 5.23) · 2,596 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.92 (0.45 to 3.38) · 845 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.1 (1.78 to 4.42) · 2,439 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.71 (5.69 to 17.72) · 885 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.28 (3.75 to 10.81) · 829 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 563 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.2 (0 to 0.72) · 9,080 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 283 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.389 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.485 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.507 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 255 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 849 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 19.2 · 201 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -8.4 · 584 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.6 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 895 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.3 to 6.9) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 273 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 108 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 341 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (10.2 to 16.1) · 2,334 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 717 cases | No different | Jan 2024 – Dec 2024 |
What patients said (655 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for St Joseph'S Medical Center of Stockton
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.08 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.34 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.51 (0.54 to 2.47) · 1,424 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.78 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.22 (98.08 to 180.36) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 127 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 98 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.9 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.2 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.4 · 405 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9 · 337 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,812 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.09 to 0.49) · 6,528 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,304 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.48 (1.49 to 5.48) · 1,467 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.27 (0 to 2.79) · 464 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.22 (0.81 to 3.64) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.16 (1.3 to 13.02) · 455 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.22 (1.5 to 8.93) · 456 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.24 (0.78 to 3.71) · 262 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.03 (0.53 to 1.53) · 6,521 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.537 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.486 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.646 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 484 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 878 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.2 · 265 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 17.1 · 493 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 407 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 615 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.1 · 184 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 164 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 290 cases | No different | Jan 2024 – Dec 2024 |
What patients said (541 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Sutter Amador Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 1 better, 7 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 180 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.6 to 1.5) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 139 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 233 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 803 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,886 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,831 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.13 (0.63 to 5.63) · 209 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 25 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.59 (0.88 to 4.3) · 188 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.99 (0 to 18.96) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.23) · 65 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.81 (0 to 1.84) · 1,604 cases | No different | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.7 · 138 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 0.9 · 139 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -27.8 · 230 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.5 · 226 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.1) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (6.9 to 14.9) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.1 to 18.6) · 146 cases | No different | Jan 2022 – Dec 2024 |
What patients said (385 patients answered, 23% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 84% |
| Nurses "always" communicated well | 84% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 68% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 81% |
| Nurses "always" explained things so they could understand | 80% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 54% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$614,654
Medicare paid this office $614,654 for 891 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 108 | $248,371 | $296 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 334 | $84,104 | $67 |
| Return visit (30+ min) | 369 | $52,828 | $75 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 291 | $51,333 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 179 | $51,125 | $100 |
See all 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 108 | $248,371 | $296 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 334 | $84,104 | $67 |
| Return visit (30+ min) | 369 | $52,828 | $75 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 291 | $51,333 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 179 | $51,125 | $100 |
| Home dialysis services per month (20 years or older) | 23 | $38,691 | $246 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 48 | $34,460 | $250 |
| Short return visit (20+ min) | 186 | $14,420 | $55 |
| New patient visit (60+ min) | 73 | $12,521 | $172 |
| Dialysis services, 1 physician visit per month (20 years or older) | 27 | $7,480 | $174 |
| Hemodialysis procedure with physician evaluation | 44 | $5,768 | $60 |
| Long return visit (40+ min) | 31 | $4,705 | $131 |
| Critical care, first 30-74 minutes | 17 | $3,017 | $177 |
Who their Medicare patients are
891 Original Medicare patients in 2024. Average age 74 · Under 65 13% · 85 and older 17% · Women 49% · Also on Medicaid 54% · Health risk score 3.36. At or below the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 64% · Coronary heart disease 52% · Heart failure 49% · Atrial fibrillation 31% · COPD 24% · Depression 23% · Dementia 18% · Stroke 16% · Cancer 12%.
The office billed $1,651,916, Medicare allowed $781,382 and paid $614,654; for 4,604 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 891 | 4,604 | 74 | 3.36 | $1,651,916 | $614,654 |
| 2023 | 857 | 4,270 | 74 | 3.26 | $1,579,372 | $571,118 |
| 2022 | 966 | 4,776 | 74 | 2.99 | $1,545,524 | $583,896 |
| 2021 | 962 | 4,369 | 73 | 2.88 | $1,503,344 | $577,326 |
| 2020 | 978 | 4,356 | 73 | 3.40 | $1,637,609 | $534,486 |
| 2019 | 1,006 | 4,283 | 73 | 3.39 | $1,570,305 | $504,107 |
| 2018 | 950 | 4,313 | 73 | 3.47 | $1,605,220 | $496,652 |
| 2017 | 943 | 4,468 | 73 | 3.56 | $1,612,675 | $505,793 |
| 2016 | 911 | 4,696 | 72 | 3.67 | $1,599,160 | $506,539 |
| 2015 | 942 | 4,495 | 72 | 3.36 | $1,472,954 | $503,907 |
| 2014 | 869 | 4,162 | 73 | 3.17 | $1,215,887 | $462,612 |
| 2013 | 816 | 3,658 | 72 | 3.23 | $1,001,832 | $389,129 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 108 | $243,705 | $289 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 288 | $61,865 | $65 |
| Return visit (30+ min) | 386 | $58,274 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 159 | $48,069 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 203 | $33,521 | $141 |
| Home dialysis services per month (20 years or older) | 20 | $33,181 | $240 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 41 | $30,815 | $241 |
| New patient visit (60+ min) | 87 | $14,209 | $163 |
| Short return visit (20+ min) | 81 | $7,694 | $59 |
| Dialysis services, 1 physician visit per month (20 years or older) | 20 | $6,815 | $166 |
| Critical care, first 30-74 minutes | 32 | $6,762 | $165 |
| Long return visit (40+ min) | 48 | $6,156 | $118 |
| Hemodialysis procedure with physician evaluation | 46 | $5,821 | $58 |
| Telephone medical discussion with physician, 11-20 minutes | 66 | $4,642 | $62 |
| Transitional care management services for problem of high complexity | 13 | $2,546 | $196 |
| Telephone medical discussion with physician, 21-30 minutes | 33 | $2,225 | $67 |
2022: 17 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 98 | $205,764 | $296 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 365 | $78,277 | $58 |
| Return visit (30+ min) | 391 | $67,403 | $102 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 54 | $44,405 | $244 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 227 | $42,305 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 152 | $35,309 | $84 |
| Home dialysis services per month (20 years or older) | 13 | $22,354 | $246 |
| New patient visit (60+ min) | 83 | $13,843 | $167 |
| Critical care, first 30-74 minutes | 50 | $11,540 | $175 |
| Short return visit (20+ min) | 103 | $9,902 | $67 |
| Hemodialysis procedure with physician evaluation | 58 | $9,483 | $60 |
| Telephone medical discussion with physician, 11-20 minutes | 108 | $9,332 | $67 |
| Long return visit (40+ min) | 48 | $8,383 | $150 |
| Dialysis services, 1 physician visit per month (20 years or older) | 19 | $8,116 | $169 |
| Telephone medical discussion with physician, 21-30 minutes | 58 | $7,024 | $100 |
| Transitional care management services for problem of high complexity | 12 | $2,794 | $233 |
| Dialysis services, per day, less than full month service (20 years or older) | 12 | $1,948 | $8 |
2021: 15 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 99 | $237,735 | $301 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 309 | $59,880 | $59 |
| Return visit (30+ min) | 355 | $55,956 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 146 | $42,011 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 195 | $36,720 | $164 |
| Home dialysis services per month (20 years or older) | 14 | $23,712 | $250 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 38 | $23,240 | $250 |
| New patient visit (60+ min) | 103 | $17,089 | $166 |
| Critical care, first 30-74 minutes | 48 | $17,019 | $181 |
| Short return visit (20+ min) | 150 | $13,596 | $64 |
| Telephone medical discussion with physician, 21-30 minutes | 84 | $9,568 | $100 |
| Telephone medical discussion with physician, 11-20 minutes | 98 | $8,154 | $69 |
| Hemodialysis procedure with physician evaluation | 56 | $6,441 | $61 |
| Long return visit (40+ min) | 39 | $6,418 | $153 |
| Transitional care management services for problem of at least moderate complexity | 12 | $2,101 | $175 |
2020: 15 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 117 | $229,013 | $240 |
| Return visit (30+ min) | 456 | $59,908 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 258 | $50,837 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 191 | $39,843 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 142 | $29,961 | $87 |
| Home dialysis services per month (20 years or older) | 19 | $28,130 | $200 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 45 | $21,663 | $201 |
| Short return visit (20+ min) | 177 | $17,747 | $55 |
| Critical care, first 30-74 minutes | 45 | $11,448 | $185 |
| New patient visit (60+ min) | 71 | $10,849 | $153 |
| Telephone medical discussion with physician, 11-20 minutes | 96 | $6,925 | $62 |
| Hemodialysis procedure with physician evaluation | 55 | $6,900 | $61 |
| Dialysis services, 1 physician visit per month (20 years or older) | 17 | $6,100 | $156 |
| Telephone medical discussion with physician, 21-30 minutes | 60 | $5,921 | $91 |
| Long return visit (40+ min) | 22 | $2,939 | $122 |
2019: 16 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 116 | $231,523 | $233 |
| Return visit (30+ min) | 533 | $71,824 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 212 | $37,692 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 158 | $31,491 | $166 |
| Short return visit (20+ min) | 294 | $24,765 | $56 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 48 | $22,494 | $191 |
| Home dialysis services per month (20 years or older) | 19 | $20,945 | $190 |
| New patient visit (60+ min) | 127 | $20,545 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 88 | $15,329 | $85 |
| Hemodialysis procedure with physician evaluation | 65 | $7,305 | $60 |
| Dialysis services, 1 physician visit per month (20 years or older) | 15 | $5,117 | $151 |
| Critical care, first 30-74 minutes | 13 | $3,266 | $181 |
| Long return visit (40+ min) | 24 | $2,809 | $117 |
| Dialysis services, per day, less than full month service (20 years or older) | 13 | $1,920 | $7 |
| New patient visit (45+ min) | 13 | $1,772 | $136 |
| Injection of drug or substance under skin or into muscle | 19 | $932 | $13 |
2018: 15 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 137 | $234,617 | $226 |
| Return visit (30+ min) | 503 | $71,062 | $79 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 158 | $32,601 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 188 | $32,325 | $58 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 48 | $23,063 | $186 |
| Short return visit (20+ min) | 291 | $23,022 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $20,328 | $84 |
| New patient visit (60+ min) | 125 | $19,528 | $156 |
| Home dialysis services per month (20 years or older) | 13 | $14,984 | $183 |
| Hemodialysis procedure with physician evaluation | 70 | $9,540 | $59 |
| Dialysis services, 1 physician visit per month (20 years or older) | 20 | $4,490 | $145 |
| Long return visit (40+ min) | 35 | $4,250 | $118 |
| Critical care, first 30-74 minutes | 12 | $2,679 | $179 |
| Dialysis services, per day, less than full month service (20 years or older) | 11 | $1,838 | $6 |
| Injection of drug or substance under skin or into muscle | 19 | $842 | $17 |
2017: 15 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 126 | $247,409 | $227 |
| Return visit (30+ min) | 483 | $72,108 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 192 | $39,707 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 212 | $34,399 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 135 | $21,221 | $83 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 39 | $19,375 | $192 |
| New patient visit (60+ min) | 104 | $15,174 | $146 |
| Short return visit (20+ min) | 215 | $14,054 | $52 |
| Home dialysis services per month (20 years or older) | 11 | $12,239 | $183 |
| Hemodialysis procedure with physician evaluation | 73 | $7,850 | $59 |
| Critical care, first 30-74 minutes | 24 | $5,033 | $180 |
| Long return visit (40+ min) | 37 | $4,303 | $105 |
| Dialysis services, 1 physician visit per month (20 years or older) | 21 | $3,607 | $144 |
| Dialysis services, per day, less than full month service (20 years or older) | 15 | $3,037 | $6 |
| Injection of drug or substance under skin or into muscle | 30 | $1,691 | $19 |
2016: 16 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 122 | $221,597 | $228 |
| Return visit (30+ min) | 528 | $85,537 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 208 | $43,022 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 215 | $39,695 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 203 | $39,512 | $163 |
| New patient visit (60+ min) | 95 | $15,141 | $159 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 34 | $14,536 | $191 |
| Home dialysis services per month (20 years or older) | 16 | $10,940 | $150 |
| Hemodialysis procedure with physician evaluation | 72 | $9,742 | $59 |
| Critical care, first 30-74 minutes | 25 | $5,943 | $180 |
| Long return visit (40+ min) | 49 | $5,694 | $114 |
| Dialysis services, 1 physician visit per month (20 years or older) | 18 | $4,357 | $145 |
| Short return visit (20+ min) | 65 | $3,975 | $58 |
| Dialysis services, per day, less than full month service (20 years or older) | 13 | $3,145 | $6 |
| Injection of drug or substance under skin or into muscle | 26 | $1,802 | $21 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,547 | $110 |
2015: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 107 | $187,492 | $228 |
| Return visit (30+ min) | 524 | $84,754 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 312 | $59,082 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 303 | $58,623 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 230 | $41,871 | $85 |
| New patient visit (60+ min) | 105 | $17,037 | $162 |
| Home dialysis services per month (20 years or older) | 14 | $11,034 | $181 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 39 | $10,166 | $178 |
| Hemodialysis procedure with physician evaluation | 66 | $8,375 | $59 |
| Long return visit (40+ min) | 67 | $8,348 | $111 |
| Dialysis services, 1 physician visit per month (20 years or older) | 24 | $6,942 | $151 |
| Critical care, first 30-74 minutes | 27 | $5,424 | $181 |
| Short return visit (20+ min) | 15 | $1,022 | $54 |
| Injection of drug or substance under skin or into muscle | 14 | $801 | $20 |
2014: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 93 | $169,160 | $226 |
| Return visit (30+ min) | 490 | $87,339 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 271 | $52,108 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 263 | $51,157 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 186 | $39,947 | $83 |
| New patient visit (60+ min) | 94 | $15,169 | $161 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 23 | $8,539 | $190 |
| Hemodialysis procedure with physician evaluation | 55 | $6,717 | $58 |
| Critical care, first 30-74 minutes | 29 | $6,447 | $179 |
| Long return visit (40+ min) | 55 | $6,359 | $112 |
| Dialysis services, 1 physician visit per month (20 years or older) | 12 | $2,711 | $151 |
| Injection of drug or substance under skin or into muscle | 15 | $1,172 | $20 |
| Short return visit (20+ min) | 20 | $1,022 | $44 |
2013: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 81 | $118,486 | $222 |
| Return visit (30+ min) | 476 | $78,331 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 270 | $48,936 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 275 | $46,074 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 206 | $34,110 | $81 |
| New patient visit (60+ min) | 102 | $16,015 | $157 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 29 | $9,794 | $192 |
| Critical care, first 30-74 minutes | 38 | $8,814 | $173 |
| Hemodialysis procedure with physician evaluation | 62 | $8,343 | $57 |
| Long return visit (40+ min) | 47 | $6,106 | $115 |
| Dialysis services, 1 physician visit per month (20 years or older) | 14 | $2,247 | $150 |
| Short return visit (20+ min) | 22 | $1,251 | $54 |
| Dialysis services, per day, less than full month service (20 years or older) | 13 | $405 | $6 |
Medicaid work
$228,356 in 2024
Medicaid paid $228,356 for 3,138 billed services this clinician did in 2024, up to 78 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 637 | $127,742 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 1,219 | $40,382 |
| 1ST HOSP IP/OBS HIGH 75 | 314 | $20,262 |
| Return visit (30+ min) | 424 | $18,806 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 491 | $17,242 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 12 | $2,369 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 28 | $1,399 |
| Short return visit (20+ min) | 13 | $153 |
| 2024 | 3,138 | 8 | 78 | $228,356 |
| 2023 | 3,319 | 7 | 75 | $230,547 |
| 2022 | 3,808 | 12 | 54 | $202,995 |
| 2021 | 5,732 | 11 | 53 | $221,057 |
| 2020 | 5,399 | 12 | 88 | $211,296 |
| 2019 | 5,518 | 11 | 89 | $216,166 |
| 2018 | 6,697 | 12 | 89 | $201,122 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 762 | $132,658 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 1,192 | $37,390 |
| Return visit (30+ min) | 543 | $21,270 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 509 | $18,534 |
| 1ST HOSP IP/OBS HIGH 75 | 268 | $17,219 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 31 | $1,964 |
| New patient visit (60+ min) | 14 | $1,513 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 580 | $126,033 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 1,029 | $34,011 |
| Return visit (30+ min) | 362 | $14,568 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 327 | $12,478 |
| 1ST HOSP IP/OBS HIGH 75 | 174 | $12,277 |
| Darbepoetin alfa, esrd use | 134 | $1,433 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 33 | $1,279 |
| Long return visit (40+ min) | 12 | $807 |
| Iron sucrose injection | 42 | $109 |
| Urea nitrogen; quantitative | 29 | $0 |
| BLOOD COUNT RETICULOCYTE AUTOMATED | 12 | $0 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 1,074 | $0 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 583 | $130,766 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 966 | $36,059 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 518 | $23,009 |
| 1ST HOSP IP/OBS HIGH 75 | 176 | $13,337 |
| Return visit (30+ min) | 296 | $12,602 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 34 | $4,961 |
| Iron sucrose injection | 99 | $323 |
| Urea nitrogen; quantitative | 36 | $0 |
| BLOOD COUNT RETICULOCYTE AUTOMATED | 27 | $0 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 2,613 | $0 |
| Darbepoetin alfa, esrd use | 384 | $0 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 791 | $156,492 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 528 | $18,064 |
| Return visit (30+ min) | 454 | $15,413 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 208 | $10,138 |
| 1ST HOSP IP/OBS HIGH 75 | 73 | $5,287 |
| Darbepoetin alfa, esrd use | 491 | $2,805 |
| New patient visit (60+ min) | 17 | $2,472 |
| Iron sucrose injection | 146 | $424 |
| Short return visit (20+ min) | 26 | $202 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 14 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 40 | $0 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 2,611 | $0 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 1,021 | $160,052 |
| Darbepoetin alfa, esrd use | 588 | $19,152 |
| Return visit (30+ min) | 480 | $18,568 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 327 | $11,815 |
| 1ST HOSP IP/OBS HIGH 75 | 66 | $4,368 |
| Iron sucrose injection | 223 | $2,083 |
| Short return visit (20+ min) | 26 | $129 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 16 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 35 | $0 |
| BLOOD COUNT RETICULOCYTE AUTOMATED | 25 | $0 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 2,711 | $0 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 1,021 | $143,036 |
| Return visit (30+ min) | 474 | $24,090 |
| Darbepoetin alfa, esrd use | 778 | $14,404 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 184 | $6,155 |
| Iron sucrose injection | 602 | $5,575 |
| 1ST HOSP IP/OBS HIGH 75 | 47 | $3,593 |
| New patient visit (60+ min) | 17 | $2,220 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 12 | $1,871 |
| Short return visit (20+ min) | 16 | $178 |
| Urea nitrogen; quantitative | 30 | $0 |
| BLOOD COUNT RETICULOCYTE AUTOMATED | 13 | $0 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 3,503 | $0 |
Drugs they prescribed that Part D paid
$900,617
Pharmacies billed $900,617 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 5,810) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
5,148 generic and fewer than 11 brand-name prescriptions · $900,617 in drug cost · 152 antibiotic prescriptions to 119 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Velphoro | 57 | $240,200 | $4,214 |
| Farxiga | 143 | $150,982 | $1,056 |
| Lokelma | 70 | $97,175 | $1,388 |
| Jardiance | 90 | $85,144 | $946 |
| Veltassa | 44 | $75,240 | $1,710 |
See all 55 drugs
| Velphoro | 57 | $240,200 | $4,214 |
| Farxiga | 143 | $150,982 | $1,056 |
| Lokelma | 70 | $97,175 | $1,388 |
| Jardiance | 90 | $85,144 | $946 |
| Veltassa | 44 | $75,240 | $1,710 |
| Sevelamer Carbonate | 149 | $45,364 | $304 |
| Procrit | 27 | $24,441 | $905 |
| Calcitriol | 1,030 | $15,628 | $15 |
| Calcium Acetate | 201 | $14,386 | $72 |
| Prosol | 88 | $12,856 | $146 |
| Dapagliflozin | 12 | $11,061 | $922 |
| Cinacalcet | 20 | $6,894 | $345 |
| Metoprolol | 252 | $4,998 | $20 |
| Hydralazine | 321 | $4,953 | $15 |
| Midodrine | 87 | $4,088 | $47 |
| Bumetanide | 106 | $3,405 | $32 |
| Losartan | 337 | $3,055 | $9 |
| Amlodipine Besylate | 377 | $2,534 | $7 |
| Nifedipine Er | 57 | $1,811 | $32 |
| Furosemide | 248 | $1,707 | $7 |
| Potassium Chloride | 109 | $1,699 | $16 |
| Minoxidil | 56 | $1,670 | $30 |
| Droxidopa | 12 | $1,643 | $137 |
| Torsemide | 103 | $1,618 | $16 |
| Allopurinol | 181 | $1,592 | $9 |
| Lisinopril | 199 | $1,569 | $8 |
| Losartan-Hydrochlorothiazide | 70 | $1,533 | $22 |
| Tamsulosin | 95 | $1,221 | $13 |
| Isosorbide Mononitrate Er | 89 | $1,005 | $11 |
| Carvedilol | 121 | $952 | $8 |
| Hydrochlorothiazide | 133 | $804 | $6 |
| Metoprolol | 60 | $680 | $11 |
| Chlorthalidone | 33 | $581 | $18 |
| Labetalol | 22 | $461 | $21 |
| Valsartan | 12 | $442 | $37 |
| Irbesartan | 19 | $424 | $22 |
| Famotidine | 27 | $392 | $15 |
| Cephalexin | 101 | $333 | $3 |
| Clonidine | 43 | $297 | $7 |
| Ondansetron | 28 | $277 | $10 |
| Lisinopril-Hydrochlorothiazide | 31 | $242 | $8 |
| Atorvastatin | 51 | $229 | $4 |
| Colchicine | 13 | $186 | $14 |
| Glipizide Er | 13 | $137 | $11 |
| Benazepril | 15 | $130 | $9 |
| Ciprofloxacin | 26 | $115 | $4 |
| Lactulose | 13 | $112 | $9 |
| Ondansetron Odt | 13 | $109 | $8 |
| Gabapentin | 15 | $90 | $6 |
| Atenolol | 11 | $77 | $7 |
| Spironolactone | 13 | $66 | $5 |
| Hydroxyzine Pamoate | 12 | $65 | $5 |
| Pantoprazole | 12 | $53 | $4 |
| Azithromycin | 15 | $53 | $4 |
| Olmesartan Medoxomil | 12 | $40 | $3 |
Year by year
| 2024 | 5,810 | 793 | 0% (0) | None | $900,617 |
| 2023 | 5,526 | 817 | 0% (0) | None | $795,124 |
| 2022 | 5,229 | 779 | 0% (0) | None | $514,525 |
| 2021 | 5,513 | 756 | None | None | $517,062 |
| 2020 | 5,695 | 740 | None | 14% | $664,195 |
| 2019 | 5,873 | 695 | 1% (29) | 16% | $665,111 |
| 2018 | 5,914 | 677 | 1% (31) | 16% | $680,424 |
| 2017 | 5,940 | 593 | 1% (41) | 20% | $902,214 |
| 2016 | 5,541 | 581 | 1% (39) | 21% | $737,146 |
| 2015 | 5,019 | 499 | 1% (44) | 22% | $484,528 |
| 2014 | 4,890 | 478 | 2% (71) | 24% | $468,350 |
| 2013 | 4,267 | 418 | 2% (76) | 27% | $326,502 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 57 drugs
| Lokelma | 83 | $107,967 | $1,301 |
| Farxiga | 86 | $107,350 | $1,248 |
| Velphoro | 23 | $99,973 | $4,347 |
| Veltassa | 39 | $61,727 | $1,583 |
| Sevelamer Carbonate | 127 | $58,319 | $459 |
| Renvela | 21 | $49,577 | $2,361 |
| Auryxia | 20 | $44,400 | $2,220 |
| Procrit | 44 | $26,099 | $593 |
| Calcium Acetate | 169 | $22,387 | $132 |
| Prosol | 139 | $22,165 | $159 |
| Cinacalcet | 17 | $17,938 | $1,055 |
| Calcitriol | 886 | $17,792 | $20 |
| Clinisol | 64 | $13,357 | $209 |
| Midodrine | 77 | $9,753 | $127 |
| Metoprolol | 271 | $8,150 | $30 |
| Sevelamer | 13 | $7,974 | $613 |
| Losartan | 340 | $7,129 | $21 |
| Hydralazine | 301 | $7,075 | $24 |
| Amlodipine Besylate | 436 | $5,973 | $14 |
| Bumetanide | 90 | $4,118 | $46 |
| Nifedipine Er | 50 | $3,296 | $66 |
| Lisinopril | 214 | $3,158 | $15 |
| Minoxidil | 47 | $3,028 | $64 |
| Furosemide | 244 | $2,816 | $12 |
| Edarbi | 12 | $2,755 | $230 |
| Potassium Chloride | 80 | $2,682 | $34 |
| Torsemide | 113 | $2,617 | $23 |
| Tamsulosin | 88 | $2,554 | $29 |
| Allopurinol | 159 | $2,435 | $15 |
| Doxercalciferol | 13 | $2,240 | $172 |
| Losartan-Hydrochlorothiazide | 53 | $1,731 | $33 |
| Isosorbide Mononitrate Er | 67 | $1,679 | $25 |
| Droxidopa | 13 | $1,599 | $123 |
| Carvedilol | 103 | $1,530 | $15 |
| Megestrol Acetate | 16 | $1,297 | $81 |
| Metoprolol | 81 | $1,164 | $14 |
| Famotidine | 58 | $1,135 | $20 |
| Chlorthalidone | 32 | $1,132 | $35 |
| Labetalol | 13 | $1,125 | $87 |
| Hydrochlorothiazide | 111 | $1,068 | $10 |
| Irbesartan | 21 | $955 | $45 |
| Mirtazapine | 14 | $897 | $64 |
| Colchicine | 13 | $816 | $63 |
| Clonidine | 43 | $798 | $19 |
| Atorvastatin | 43 | $567 | $13 |
| Valsartan | 14 | $480 | $34 |
| Ondansetron | 34 | $480 | $14 |
| Benazepril | 23 | $424 | $18 |
| Cephalexin | 79 | $412 | $5 |
| Lisinopril-Hydrochlorothiazide | 25 | $373 | $15 |
| Doxazosin Mesylate | 11 | $275 | $25 |
| Mycophenolate Mofetil | 11 | $269 | $24 |
| Omeprazole | 11 | $268 | $24 |
| Atenolol | 16 | $219 | $14 |
| Gabapentin | 33 | $209 | $6 |
| Ciprofloxacin | 27 | $150 | $6 |
| Azithromycin | 18 | $128 | $7 |
2022: 55 drugs
| Sevelamer Carbonate | 130 | $74,596 | $574 |
| Renvela | 29 | $74,463 | $2,568 |
| Lokelma | 65 | $55,947 | $861 |
| Auryxia | 19 | $42,261 | $2,224 |
| Clinisol | 197 | $29,886 | $152 |
| Farxiga | 23 | $24,613 | $1,070 |
| Lanthanum Carbonate | 20 | $24,374 | $1,219 |
| Procrit | 38 | $21,037 | $554 |
| Calcium Acetate | 112 | $14,140 | $126 |
| Januvia | 18 | $12,389 | $688 |
| Calcitriol | 651 | $11,685 | $18 |
| Clinolipid | 32 | $11,177 | $349 |
| Prosol | 39 | $7,340 | $188 |
| Hydralazine | 279 | $6,855 | $25 |
| Bumetanide | 125 | $6,480 | $52 |
| Metoprolol | 290 | $6,291 | $22 |
| Losartan | 345 | $4,686 | $14 |
| Midodrine | 42 | $4,289 | $102 |
| Amlodipine Besylate | 398 | $3,479 | $9 |
| Nifedipine Er | 76 | $2,790 | $37 |
| Potassium Chloride | 101 | $2,729 | $27 |
| Edarbi | 11 | $2,436 | $221 |
| Megestrol Acetate | 33 | $2,333 | $71 |
| Lisinopril | 199 | $2,293 | $12 |
| Furosemide | 287 | $2,186 | $8 |
| Retacrit | 11 | $2,127 | $193 |
| Minoxidil | 36 | $1,972 | $55 |
| Tamsulosin | 83 | $1,858 | $22 |
| Doxercalciferol | 13 | $1,773 | $136 |
| Allopurinol | 136 | $1,762 | $13 |
| Carvedilol | 130 | $1,745 | $13 |
| Colchicine | 17 | $1,249 | $73 |
| Losartan-Hydrochlorothiazide | 36 | $1,216 | $34 |
| Atorvastatin | 91 | $1,111 | $12 |
| Famotidine | 76 | $1,000 | $13 |
| Diltiazem 24hr Er (Cd) | 20 | $832 | $42 |
| Torsemide | 51 | $808 | $16 |
| Labetalol | 15 | $785 | $52 |
| Isosorbide Mononitrate Er | 55 | $762 | $14 |
| Hydrochlorothiazide | 126 | $736 | $6 |
| Chlorthalidone | 15 | $609 | $41 |
| Clonidine | 45 | $595 | $13 |
| Metoprolol | 59 | $494 | $8 |
| Mirtazapine | 12 | $466 | $39 |
| Olmesartan Medoxomil | 17 | $444 | $26 |
| Ondansetron | 19 | $380 | $20 |
| Lidocaine-Prilocaine | 16 | $353 | $22 |
| Benazepril | 52 | $353 | $7 |
| Doxazosin Mesylate | 13 | $313 | $24 |
| Cephalexin | 61 | $311 | $5 |
| Lactulose | 16 | $244 | $15 |
| Lisinopril-Hydrochlorothiazide | 32 | $240 | $7 |
| Gabapentin | 21 | $206 | $10 |
| Ciprofloxacin | 25 | $133 | $5 |
| Glipizide | 12 | $62 | $5 |
2021: 61 drugs
| Auryxia | 32 | $74,094 | $2,315 |
| Renvela | 67 | $71,201 | $1,063 |
| Sevelamer Carbonate | 124 | $47,584 | $384 |
| Lokelma | 41 | $37,486 | $914 |
| Procrit | 44 | $29,921 | $680 |
| Clinisol | 232 | $26,289 | $113 |
| Januvia | 61 | $23,955 | $393 |
| Lanthanum Carbonate | 16 | $21,082 | $1,318 |
| Calcium Acetate | 161 | $20,065 | $125 |
| Calcitriol | 653 | $16,058 | $25 |
| Lantus Solostar | 23 | $12,259 | $533 |
| Veltassa | 12 | $11,994 | $1,000 |
| Clinolipid | 32 | $10,244 | $320 |
| Prosol | 45 | $6,802 | $151 |
| Metoprolol | 304 | $6,559 | $22 |
| Tradjenta | 12 | $6,196 | $516 |
| Hydralazine | 295 | $5,007 | $17 |
| Losartan | 356 | $4,074 | $11 |
| Bumetanide | 86 | $3,876 | $45 |
| Amlodipine Besylate | 456 | $3,731 | $8 |
| Insulin Lispro Kwikpen U-100 | 12 | $3,293 | $274 |
| Minoxidil | 57 | $2,855 | $50 |
| Potassium Chloride | 108 | $2,845 | $26 |
| Nifedipine Er | 82 | $2,531 | $31 |
| Retacrit | 14 | $2,407 | $172 |
| Lisinopril | 252 | $2,100 | $8 |
| Tamsulosin | 97 | $1,936 | $20 |
| Carvedilol | 142 | $1,777 | $13 |
| Furosemide | 292 | $1,728 | $6 |
| Labetalol | 24 | $1,702 | $71 |
| Famotidine | 76 | $1,683 | $22 |
| Atorvastatin | 113 | $1,598 | $14 |
| Midodrine | 28 | $1,445 | $52 |
| Allopurinol | 93 | $984 | $11 |
| Losartan-Hydrochlorothiazide | 36 | $875 | $24 |
| Hydrochlorothiazide | 110 | $785 | $7 |
| Irbesartan | 12 | $677 | $56 |
| Diltiazem 24hr Er (Cd) | 18 | $668 | $37 |
| Clonidine | 47 | $662 | $14 |
| Isosorbide Mononitrate Er | 24 | $627 | $26 |
| Olmesartan Medoxomil | 21 | $585 | $28 |
| Doxazosin Mesylate | 19 | $525 | $28 |
| Lidocaine-Prilocaine | 35 | $506 | $14 |
| Chlorthalidone | 12 | $438 | $36 |
| Benazepril | 68 | $361 | $5 |
| Pregabalin | 17 | $344 | $20 |
| Metoprolol | 37 | $327 | $9 |
| Torsemide | 30 | $322 | $11 |
| Omeprazole | 24 | $314 | $13 |
| Glipizide Er | 13 | $313 | $24 |
| Gabapentin | 35 | $273 | $8 |
| Lactulose | 14 | $184 | $13 |
| Glipizide | 23 | $181 | $8 |
| Metformin | 14 | $137 | $10 |
| Ciprofloxacin | 19 | $128 | $7 |
| Cephalexin | 28 | $119 | $4 |
| Mirtazapine | 11 | $106 | $10 |
| Atenolol | 11 | $105 | $10 |
| Lisinopril-Hydrochlorothiazide | 21 | $89 | $4 |
| Alprazolam | 12 | $81 | $7 |
| Amoxicillin | 11 | $47 | $4 |
2020: 64 drugs
| Auryxia | 75 | $116,579 | $1,554 |
| Renvela | 39 | $114,126 | $2,926 |
| Sevelamer Carbonate | 144 | $54,494 | $378 |
| Procrit | 72 | $52,467 | $729 |
| Lokelma | 33 | $28,886 | $875 |
| Prosol | 101 | $28,351 | $281 |
| Clinisol | 221 | $26,673 | $121 |
| Januvia | 23 | $21,139 | $919 |
| Calcitriol | 738 | $16,125 | $22 |
| Veltassa | 17 | $15,800 | $929 |
| Calcium Acetate | 141 | $13,714 | $97 |
| Tradjenta | 12 | $5,795 | $483 |
| Metoprolol | 242 | $5,278 | $22 |
| Hydralazine | 241 | $5,123 | $21 |
| Bumetanide | 102 | $4,359 | $43 |
| Retacrit | 18 | $3,955 | $220 |
| Losartan | 362 | $3,836 | $11 |
| Potassium Chloride | 130 | $3,738 | $29 |
| Minoxidil | 91 | $2,911 | $32 |
| Amlodipine Besylate | 420 | $2,885 | $7 |
| Nifedipine Er | 59 | $2,603 | $44 |
| Clonidine | 11 | $2,077 | $189 |
| Lisinopril | 278 | $2,024 | $7 |
| Losartan-Hydrochlorothiazide | 28 | $1,942 | $69 |
| Potassium Citrate Er | 11 | $1,678 | $153 |
| Furosemide | 228 | $1,585 | $7 |
| Midodrine | 38 | $1,442 | $38 |
| Famotidine | 89 | $1,379 | $15 |
| Labetalol | 24 | $1,331 | $55 |
| Atorvastatin | 99 | $1,260 | $13 |
| Carvedilol | 164 | $1,230 | $7 |
| Tamsulosin | 104 | $1,162 | $11 |
| Betamethasone Dipropionate | 13 | $845 | $65 |
| Isosorbide Mononitrate Er | 39 | $834 | $21 |
| Lidocaine-Prilocaine | 48 | $795 | $17 |
| Allopurinol | 84 | $782 | $9 |
| Valsartan | 13 | $699 | $54 |
| Repaglinide | 12 | $669 | $56 |
| Olmesartan Medoxomil | 26 | $636 | $24 |
| Clonidine | 45 | $635 | $14 |
| Hydrochlorothiazide | 78 | $608 | $8 |
| Chlorthalidone | 13 | $525 | $40 |
| Amlodipine Besylate-Benazepril | 16 | $456 | $28 |
| Gabapentin | 68 | $427 | $6 |
| Irbesartan | 13 | $385 | $30 |
| Metoprolol | 34 | $362 | $11 |
| Torsemide | 36 | $296 | $8 |
| Fluticasone Propionate | 18 | $288 | $16 |
| Cephalexin | 67 | $282 | $4 |
| Ondansetron | 16 | $272 | $17 |
| Benazepril | 31 | $259 | $8 |
| Hydroxyzine | 16 | $257 | $16 |
| Glipizide | 27 | $249 | $9 |
| Ciprofloxacin | 29 | $213 | $7 |
| Mirtazapine | 27 | $212 | $8 |
| Omeprazole | 23 | $206 | $9 |
| Prednisone | 13 | $203 | $16 |
| Pravastatin | 11 | $198 | $18 |
| Pregabalin | 11 | $169 | $15 |
| Azithromycin | 23 | $146 | $6 |
| Metformin | 15 | $138 | $9 |
| Pantoprazole | 14 | $105 | $8 |
| Trazodone | 19 | $81 | $4 |
| Lisinopril-Hydrochlorothiazide | 14 | $31 | $2 |
2019: 70 drugs
| Renvela | 59 | $93,402 | $1,583 |
| Sevelamer Carbonate | 164 | $85,492 | $521 |
| Auryxia | 61 | $84,784 | $1,390 |
| Velphoro | 26 | $83,093 | $3,196 |
| Procrit | 81 | $52,144 | $644 |
| Clinisol | 234 | $33,465 | $143 |
| Januvia | 37 | $21,670 | $586 |
| Veltassa | 20 | $17,082 | $854 |
| Calcitriol | 651 | $15,460 | $24 |
| Calcium Acetate | 135 | $12,840 | $95 |
| Tradjenta | 29 | $9,656 | $333 |
| Prosol | 54 | $8,999 | $167 |
| Bumetanide | 119 | $8,654 | $73 |
| Metoprolol | 201 | $6,067 | $30 |
| Hydralazine | 274 | $5,973 | $22 |
| Potassium Chloride | 115 | $3,659 | $32 |
| Amlodipine Besylate | 401 | $2,966 | $7 |
| Losartan | 322 | $2,797 | $9 |
| Carvedilol | 212 | $2,488 | $12 |
| Intralipid | 24 | $2,411 | $100 |
| Lisinopril | 227 | $2,012 | $9 |
| Olmesartan Medoxomil | 29 | $1,957 | $67 |
| Atorvastatin | 130 | $1,857 | $14 |
| Minoxidil | 66 | $1,822 | $28 |
| Midodrine | 57 | $1,806 | $32 |
| Furosemide | 268 | $1,782 | $7 |
| Clonidine | 12 | $1,774 | $148 |
| Novolin N | 12 | $1,716 | $143 |
| Valsartan | 32 | $1,673 | $52 |
| Tamsulosin | 123 | $1,596 | $13 |
| Nifedipine Er | 39 | $1,575 | $40 |
| Famotidine | 107 | $1,460 | $14 |
| Chlorthalidone | 29 | $1,445 | $50 |
| Gabapentin | 72 | $1,031 | $14 |
| Dextrose in Water | 69 | $1,004 | $15 |
| Labetalol | 14 | $995 | $71 |
| Allopurinol | 75 | $975 | $13 |
| Isosorbide Mononitrate Er | 37 | $789 | $21 |
| Lidocaine-Prilocaine | 43 | $759 | $18 |
| Clonidine | 56 | $719 | $13 |
| Hydrochlorothiazide | 88 | $597 | $7 |
| Rosuvastatin | 12 | $579 | $48 |
| Losartan-Hydrochlorothiazide | 46 | $537 | $12 |
| Amlodipine Besylate-Benazepril | 18 | $496 | $28 |
| Metoprolol | 40 | $437 | $11 |
| Hydroxyzine | 16 | $420 | $26 |
| Pravastatin | 16 | $388 | $24 |
| Pantoprazole | 24 | $377 | $16 |
| Glipizide Er | 12 | $375 | $31 |
| Torsemide | 43 | $371 | $9 |
| Benazepril | 42 | $354 | $8 |
| Cephalexin | 69 | $334 | $5 |
| Mirtazapine | 16 | $249 | $16 |
| Ranitidine | 25 | $249 | $10 |
| Pioglitazone | 11 | $221 | $20 |
| Hydrocodone-Acetaminophen | 13 | $213 | $16 |
| Dextrose in Water | 37 | $210 | $6 |
| Azithromycin | 22 | $196 | $9 |
| Metolazone | 11 | $189 | $17 |
| Prednisone | 17 | $171 | $10 |
| Glipizide | 22 | $162 | $7 |
| Omeprazole | 19 | $131 | $7 |
| Metformin | 14 | $130 | $9 |
| Clopidogrel | 14 | $123 | $9 |
| Simvastatin | 21 | $121 | $6 |
| Trazodone | 14 | $104 | $7 |
| Triamterene-Hydrochlorothiazid | 13 | $98 | $8 |
| Alprazolam | 17 | $88 | $5 |
| Ciprofloxacin | 11 | $82 | $7 |
| Lisinopril-Hydrochlorothiazide | 17 | $68 | $4 |
2018: 79 drugs
| Renvela | 125 | $147,164 | $1,177 |
| Sevelamer Carbonate | 88 | $96,103 | $1,092 |
| Velphoro | 37 | $82,869 | $2,240 |
| Procrit | 115 | $58,002 | $504 |
| Auryxia | 44 | $52,619 | $1,196 |
| Clinisol | 195 | $29,977 | $154 |
| Januvia | 32 | $16,894 | $528 |
| Novolog Flexpen | 15 | $15,135 | $1,009 |
| Calcitriol | 523 | $12,412 | $24 |
| Veltassa | 12 | $11,708 | $976 |
| Calcium Acetate | 135 | $11,253 | $83 |
| Trulicity | 12 | $8,473 | $706 |
| Tradjenta | 16 | $6,968 | $436 |
| Metoprolol | 187 | $6,527 | $35 |
| Prosol | 39 | $6,003 | $154 |
| Bumetanide | 91 | $5,852 | $64 |
| Intralipid | 27 | $5,467 | $202 |
| Hydralazine | 275 | $4,459 | $16 |
| Clonidine | 36 | $3,532 | $98 |
| Losartan | 364 | $2,633 | $7 |
| Amlodipine Besylate | 411 | $2,549 | $6 |
| Chlorthalidone | 44 | $2,515 | $57 |
| Esomeprazole Magnesium | 13 | $2,221 | $171 |
| Potassium Chloride | 98 | $2,052 | $21 |
| Labetalol | 24 | $1,805 | $75 |
| Tamsulosin | 108 | $1,786 | $17 |
| Lisinopril | 212 | $1,765 | $8 |
| Minoxidil | 87 | $1,748 | $20 |
| Furosemide | 326 | $1,703 | $5 |
| Carvedilol | 240 | $1,657 | $7 |
| Midodrine | 86 | $1,652 | $19 |
| Famotidine | 114 | $1,524 | $13 |
| Isosorbide Dinitrate | 20 | $1,238 | $62 |
| Atorvastatin | 72 | $1,132 | $16 |
| Olmesartan Medoxomil | 15 | $995 | $66 |
| Betamethasone Dipropionate | 23 | $897 | $39 |
| Allopurinol | 75 | $866 | $12 |
| Nifedipine Er | 25 | $854 | $34 |
| Valsartan | 27 | $840 | $31 |
| Ventolin Hfa | 13 | $749 | $58 |
| Pravastatin | 21 | $714 | $34 |
| Lidocaine-Prilocaine | 29 | $664 | $23 |
| Clonidine | 57 | $623 | $11 |
| Losartan-Hydrochlorothiazide | 39 | $550 | $14 |
| Metoprolol | 63 | $533 | $8 |
| Hydrochlorothiazide | 80 | $509 | $6 |
| Levothyroxine | 35 | $499 | $14 |
| Gabapentin | 51 | $469 | $9 |
| Simvastatin | 63 | $444 | $7 |
| Glipizide Er | 19 | $416 | $22 |
| Isosorbide Mononitrate Er | 28 | $383 | $14 |
| Cephalexin | 77 | $366 | $5 |
| Benazepril | 42 | $353 | $8 |
| Hydrocodone-Acetaminophen | 23 | $322 | $14 |
| Mirtazapine | 25 | $288 | $12 |
| Amlodipine Besylate-Benazepril | 12 | $270 | $23 |
| Kionex | 15 | $251 | $17 |
| Dextrose in Water | 38 | $237 | $6 |
| Omeprazole | 32 | $223 | $7 |
| Ondansetron | 21 | $221 | $11 |
| Metolazone | 14 | $215 | $15 |
| Lisinopril-Hydrochlorothiazide | 44 | $192 | $4 |
| Triamterene-Hydrochlorothiazid | 19 | $190 | $10 |
| Glipizide | 29 | $188 | $6 |
| Azithromycin | 27 | $182 | $7 |
| Alprazolam | 25 | $174 | $7 |
| Clopidogrel | 29 | $173 | $6 |
| Lactulose | 22 | $153 | $7 |
| Prednisone | 21 | $151 | $7 |
| Escitalopram | 19 | $148 | $8 |
| Pantoprazole | 13 | $142 | $11 |
| Metformin | 24 | $141 | $6 |
| Ranitidine | 16 | $140 | $9 |
| Torsemide | 15 | $138 | $9 |
| Metoclopramide | 11 | $106 | $10 |
| Temazepam | 15 | $93 | $6 |
| Ciprofloxacin | 19 | $89 | $5 |
| Amoxicillin | 14 | $81 | $6 |
| Dextrose in Water | 25 | $78 | $3 |
2017: 75 drugs
| Renvela | 203 | $325,077 | $1,601 |
| Sensipar | 122 | $164,481 | $1,348 |
| Velphoro | 41 | $85,212 | $2,078 |
| Procrit | 156 | $80,308 | $515 |
| Clinisol | 195 | $34,263 | $176 |
| Januvia | 51 | $24,546 | $481 |
| Intralipid | 65 | $13,694 | $211 |
| Sevelamer Carbonate | 17 | $13,377 | $787 |
| Calcium Acetate | 113 | $11,311 | $100 |
| Calcitriol | 396 | $10,942 | $28 |
| Novolog Flexpen | 16 | $10,911 | $682 |
| Lantus Solostar | 13 | $7,248 | $558 |
| Metoprolol | 229 | $6,418 | $28 |
| Clonidine | 52 | $5,208 | $100 |
| Tradjenta | 12 | $4,941 | $412 |
| Hydralazine | 283 | $3,895 | $14 |
| Chlorthalidone | 65 | $3,743 | $58 |
| Bumetanide | 64 | $3,244 | $51 |
| Losartan | 376 | $2,675 | $7 |
| Potassium Chloride | 133 | $2,381 | $18 |
| Olmesartan Medoxomil | 11 | $2,369 | $215 |
| Amlodipine Besylate | 352 | $2,048 | $6 |
| Midodrine | 81 | $1,895 | $23 |
| Labetalol | 32 | $1,889 | $59 |
| Tamsulosin | 94 | $1,812 | $19 |
| Furosemide | 370 | $1,772 | $5 |
| Lisinopril | 252 | $1,756 | $7 |
| Minoxidil | 97 | $1,686 | $17 |
| Isosorbide Dinitrate | 20 | $1,565 | $78 |
| Betamethasone Dipropionate | 26 | $1,477 | $57 |
| Allopurinol | 99 | $1,128 | $11 |
| Atorvastatin | 65 | $1,080 | $17 |
| Carvedilol | 165 | $1,068 | $6 |
| Fenofibrate | 16 | $923 | $58 |
| Kionex | 25 | $920 | $37 |
| Pravastatin | 50 | $909 | $18 |
| Nifedipine Er | 29 | $885 | $31 |
| Famotidine | 111 | $876 | $8 |
| Lidocaine-Prilocaine | 44 | $872 | $20 |
| Diphenoxylate-Atropine | 14 | $811 | $58 |
| Fenofibrate | 21 | $786 | $37 |
| Valsartan | 26 | $745 | $29 |
| Levothyroxine | 60 | $689 | $11 |
| Simvastatin | 93 | $671 | $7 |
| Clonidine | 51 | $589 | $12 |
| Ultra-Fine Short Pen Needle | 14 | $553 | $39 |
| Gabapentin | 67 | $523 | $8 |
| Amlodipine Besylate-Benazepril | 14 | $459 | $33 |
| Losartan-Hydrochlorothiazide | 43 | $456 | $11 |
| Glipizide Er | 20 | $416 | $21 |
| Hydrocodone-Acetaminophen | 26 | $412 | $16 |
| Metformin | 44 | $319 | $7 |
| Dextrose in Water | 14 | $300 | $21 |
| Cephalexin | 57 | $297 | $5 |
| Omeprazole | 38 | $282 | $7 |
| Metoclopramide | 12 | $269 | $22 |
| Metoprolol | 59 | $264 | $4 |
| Sure Comfort | 12 | $254 | $21 |
| Triamterene-Hydrochlorothiazid | 25 | $253 | $10 |
| Hydrochlorothiazide | 45 | $252 | $6 |
| Ondansetron | 24 | $235 | $10 |
| Lisinopril-Hydrochlorothiazide | 58 | $225 | $4 |
| Benazepril | 29 | $206 | $7 |
| Ciprofloxacin | 25 | $201 | $8 |
| Isosorbide Mononitrate Er | 17 | $194 | $11 |
| Pantoprazole | 14 | $163 | $12 |
| Spironolactone | 11 | $151 | $14 |
| Clopidogrel | 32 | $151 | $5 |
| Ranitidine | 15 | $128 | $9 |
| Amiodarone | 12 | $128 | $11 |
| Prednisone | 13 | $122 | $9 |
| Mirtazapine | 13 | $106 | $8 |
| Meclizine | 11 | $104 | $9 |
| Azithromycin | 20 | $85 | $4 |
| Temazepam | 13 | $67 | $5 |
2016: 69 drugs
| Renvela | 217 | $299,379 | $1,380 |
| Sensipar | 137 | $169,071 | $1,234 |
| Velphoro | 18 | $43,588 | $2,422 |
| Procrit | 78 | $41,235 | $529 |
| Januvia | 50 | $21,653 | $433 |
| Clinisol | 143 | $19,951 | $140 |
| Novolog Flexpen | 20 | $11,127 | $556 |
| Calcium Acetate | 109 | $10,871 | $100 |
| Lantus Solostar | 24 | $8,283 | $345 |
| Calcitriol | 332 | $6,442 | $19 |
| Clonidine | 39 | $5,280 | $135 |
| Benicar | 22 | $5,153 | $234 |
| Tradjenta | 13 | $4,639 | $357 |
| Metoprolol | 182 | $4,220 | $23 |
| Hydralazine | 302 | $4,121 | $14 |
| Lantus | 11 | $3,146 | $286 |
| Losartan | 387 | $2,833 | $7 |
| Potassium Chloride | 143 | $2,769 | $19 |
| Lidocaine-Prilocaine | 68 | $2,592 | $38 |
| Amlodipine Besylate | 389 | $2,339 | $6 |
| Labetalol | 39 | $2,281 | $58 |
| Lisinopril | 326 | $2,098 | $6 |
| Tamsulosin | 80 | $2,050 | $26 |
| Minoxidil | 112 | $1,860 | $17 |
| Bumetanide | 50 | $1,796 | $36 |
| Furosemide | 343 | $1,594 | $5 |
| Midodrine | 67 | $1,593 | $24 |
| Bd Ultra-Fine Pen Needle | 31 | $1,185 | $38 |
| Fenofibrate | 14 | $1,101 | $79 |
| Carvedilol | 142 | $1,088 | $8 |
| Valsartan | 22 | $1,019 | $46 |
| Pravastatin | 34 | $951 | $28 |
| Fenofibrate | 13 | $928 | $71 |
| Nifedipine Er | 28 | $840 | $30 |
| Allopurinol | 84 | $757 | $9 |
| Levothyroxine | 51 | $723 | $14 |
| Gabapentin | 64 | $662 | $10 |
| Klor-Con 8 | 12 | $628 | $52 |
| Simvastatin | 75 | $618 | $8 |
| Atorvastatin | 26 | $527 | $20 |
| Mirtazapine | 32 | $516 | $16 |
| Losartan-Hydrochlorothiazide | 47 | $493 | $10 |
| Sure Comfort | 18 | $480 | $27 |
| Clonidine | 53 | $473 | $9 |
| Hydrocodone-Acetaminophen | 21 | $472 | $22 |
| Hydrochlorothiazide | 80 | $436 | $5 |
| Omeprazole | 56 | $397 | $7 |
| Ondansetron | 25 | $393 | $16 |
| Metoprolol | 83 | $376 | $5 |
| Metformin | 45 | $372 | $8 |
| Spironolactone | 20 | $370 | $18 |
| Kionex | 21 | $366 | $17 |
| Famotidine | 37 | $281 | $8 |
| Lisinopril-Hydrochlorothiazide | 40 | $240 | $6 |
| Clopidogrel | 21 | $232 | $11 |
| Glipizide | 50 | $200 | $4 |
| Nifedical Xl | 11 | $196 | $18 |
| Benazepril | 16 | $157 | $10 |
| Atenolol | 19 | $146 | $8 |
| Cephalexin | 34 | $140 | $4 |
| Azithromycin | 20 | $132 | $7 |
| Triamterene-Hydrochlorothiazid | 13 | $120 | $9 |
| Temazepam | 28 | $119 | $4 |
| Isosorbide Mononitrate Er | 11 | $107 | $10 |
| Zolpidem | 13 | $85 | $7 |
| Ciprofloxacin | 16 | $85 | $5 |
| Metoclopramide | 14 | $65 | $5 |
| Tramadol | 16 | $55 | $3 |
| Alprazolam | 22 | $55 | $3 |
2015: 69 drugs
| Renvela | 190 | $209,445 | $1,102 |
| Sensipar | 56 | $52,240 | $933 |
| Januvia | 59 | $25,416 | $431 |
| Procrit | 60 | $25,148 | $419 |
| Clinisol | 152 | $19,883 | $131 |
| Novolog Flexpen | 27 | $10,336 | $383 |
| Tradjenta | 26 | $8,771 | $337 |
| Lantus Solostar | 24 | $8,541 | $356 |
| Calcium Acetate | 90 | $8,011 | $89 |
| Calcitriol | 337 | $6,524 | $19 |
| Levemir | 15 | $5,806 | $387 |
| Novolog | 12 | $5,269 | $439 |
| Hydralazine | 216 | $3,602 | $17 |
| Metoprolol | 143 | $3,526 | $25 |
| Lantus | 13 | $3,250 | $250 |
| Potassium Chloride | 150 | $3,196 | $21 |
| Paricalcitol | 11 | $2,728 | $248 |
| Labetalol | 35 | $2,652 | $76 |
| Amlodipine Besylate | 399 | $2,489 | $6 |
| Midodrine | 62 | $2,266 | $37 |
| Lisinopril | 363 | $2,264 | $6 |
| Losartan | 287 | $2,201 | $8 |
| Fenofibrate | 15 | $1,794 | $120 |
| Valsartan | 17 | $1,701 | $100 |
| Minoxidil | 99 | $1,434 | $14 |
| Lidocaine-Prilocaine | 38 | $1,363 | $36 |
| Furosemide | 346 | $1,328 | $4 |
| Fenofibrate | 20 | $1,180 | $59 |
| Tamsulosin | 46 | $1,031 | $22 |
| Carvedilol | 117 | $879 | $8 |
| Simvastatin | 117 | $855 | $7 |
| Repaglinide | 16 | $805 | $50 |
| Bd Ultra-Fine Pen Needle | 21 | $779 | $37 |
| Nifedipine Er | 21 | $733 | $35 |
| Clonidine | 74 | $706 | $10 |
| Allopurinol | 63 | $681 | $11 |
| Atorvastatin | 48 | $681 | $14 |
| Losartan-Hydrochlorothiazide | 47 | $642 | $14 |
| Gabapentin | 52 | $598 | $12 |
| Megestrol Acetate | 12 | $556 | $46 |
| Bumetanide | 18 | $518 | $29 |
| Hydrochlorothiazide | 93 | $514 | $6 |
| Metformin | 55 | $456 | $8 |
| Omeprazole | 52 | $445 | $9 |
| Pravastatin | 15 | $388 | $26 |
| Metoprolol | 81 | $386 | $5 |
| Sure Comfort | 13 | $379 | $29 |
| Metolazone | 21 | $353 | $17 |
| Lisinopril-Hydrochlorothiazide | 40 | $279 | $7 |
| Nifedical Xl | 13 | $278 | $21 |
| Levothyroxine | 13 | $238 | $18 |
| Benazepril | 24 | $218 | $9 |
| Cephalexin | 46 | $208 | $5 |
| Isosorbide Mononitrate Er | 16 | $199 | $12 |
| Atenolol | 26 | $177 | $7 |
| Glipizide | 39 | $172 | $4 |
| Clopidogrel | 17 | $172 | $10 |
| Gemfibrozil | 16 | $150 | $9 |
| Azithromycin | 16 | $120 | $8 |
| Acetaminophen-Codeine | 11 | $115 | $10 |
| Alprazolam | 40 | $114 | $3 |
| Ciprofloxacin | 18 | $112 | $6 |
| Tramadol | 28 | $105 | $4 |
| Spironolactone | 19 | $96 | $5 |
| Temazepam | 13 | $60 | $5 |
| Amoxicillin | 14 | $58 | $4 |
| Metoclopramide | 13 | $55 | $4 |
| Famotidine | 19 | $48 | $3 |
| Zolpidem | 12 | $38 | $3 |
2014: 73 drugs
| Renvela | 166 | $145,929 | $879 |
| Sensipar | 55 | $52,686 | $958 |
| Procrit | 55 | $30,533 | $555 |
| Fosrenol | 25 | $27,275 | $1,091 |
| Januvia | 63 | $20,994 | $333 |
| Clinisol | 115 | $13,334 | $116 |
| Novolog Flexpen | 36 | $12,390 | $344 |
| Prosol | 50 | $9,433 | $189 |
| Lantus Solostar | 32 | $9,353 | $292 |
| Calcitriol | 335 | $8,609 | $26 |
| Lantus | 18 | $7,828 | $435 |
| Levemir | 17 | $6,245 | $367 |
| Calcium Acetate | 64 | $6,200 | $97 |
| Nexium | 19 | $6,051 | $318 |
| Diovan | 22 | $5,658 | $257 |
| Colcrys | 32 | $5,109 | $160 |
| Uloric | 11 | $5,102 | $464 |
| Metoprolol | 186 | $5,008 | $27 |
| Hydralazine | 234 | $4,523 | $19 |
| Paricalcitol | 20 | $3,827 | $191 |
| Humalog | 17 | $3,601 | $212 |
| Lisinopril | 417 | $3,209 | $8 |
| Tradjenta | 11 | $2,908 | $264 |
| Amlodipine Besylate | 382 | $2,421 | $6 |
| Losartan | 217 | $2,262 | $10 |
| Labetalol | 38 | $2,244 | $59 |
| Fenofibrate | 14 | $1,982 | $142 |
| Potassium Chloride | 106 | $1,816 | $17 |
| Minoxidil | 91 | $1,369 | $15 |
| Furosemide | 281 | $1,319 | $5 |
| Candesartan Cilexetil | 12 | $1,161 | $97 |
| Megestrol Acetate | 17 | $1,028 | $60 |
| Nifedipine Er | 21 | $1,018 | $48 |
| Simvastatin | 117 | $960 | $8 |
| Carvedilol | 90 | $953 | $11 |
| Fenofibrate | 14 | $805 | $58 |
| Klor-Con 8 | 15 | $798 | $53 |
| Losartan-Hydrochlorothiazide | 34 | $780 | $23 |
| Allopurinol | 96 | $702 | $7 |
| Clonidine | 94 | $697 | $7 |
| Isosorbide Mononitrate Er | 51 | $696 | $14 |
| Atorvastatin | 33 | $677 | $21 |
| Hydrocodone-Acetaminophen | 37 | $676 | $18 |
| Lidocaine-Prilocaine | 24 | $666 | $28 |
| Pravastatin | 19 | $629 | $33 |
| Bd Ultra-Fine Pen Needle | 16 | $596 | $37 |
| Metoprolol | 80 | $569 | $7 |
| Midodrine | 20 | $560 | $28 |
| Omeprazole | 57 | $555 | $10 |
| Gabapentin | 39 | $534 | $14 |
| Amlodipine Besylate-Benazepril | 15 | $516 | $34 |
| Tamsulosin | 29 | $472 | $16 |
| Hydrochlorothiazide | 75 | $450 | $6 |
| Glipizide | 43 | $389 | $9 |
| Bumetanide | 18 | $365 | $20 |
| Klor-Con M20 | 17 | $350 | $21 |
| Gemfibrozil | 20 | $336 | $17 |
| Cephalexin | 46 | $336 | $7 |
| Metformin | 36 | $287 | $8 |
| Lactulose | 23 | $284 | $12 |
| Benazepril | 21 | $266 | $13 |
| Metolazone | 15 | $218 | $15 |
| Lisinopril-Hydrochlorothiazide | 27 | $201 | $7 |
| Atenolol | 24 | $200 | $8 |
| Kionex | 11 | $198 | $18 |
| Glipizide Er | 18 | $170 | $9 |
| Levothyroxine | 13 | $166 | $13 |
| Tramadol | 27 | $151 | $6 |
| Temazepam | 29 | $125 | $4 |
| Famotidine | 19 | $110 | $6 |
| Pantoprazole | 12 | $94 | $8 |
| Alprazolam | 22 | $74 | $3 |
| Metoclopramide | 14 | $62 | $4 |
2013: 64 drugs
| Renvela | 124 | $76,756 | $619 |
| Sensipar | 35 | $28,100 | $803 |
| Procrit | 45 | $24,644 | $548 |
| Januvia | 56 | $15,354 | $274 |
| Zemplar | 41 | $13,011 | $317 |
| Prosol | 50 | $10,730 | $215 |
| Fosrenol | 11 | $10,049 | $914 |
| Megace Es | 11 | $9,870 | $897 |
| Clinisol | 43 | $9,585 | $223 |
| Novolog Flexpen | 29 | $8,577 | $296 |
| Diovan | 46 | $7,719 | $168 |
| Calcitriol | 252 | $7,610 | $30 |
| Colcrys | 50 | $6,486 | $130 |
| Calcium Acetate | 48 | $6,252 | $130 |
| Lantus Solostar | 24 | $5,770 | $240 |
| Lantus | 12 | $4,939 | $412 |
| Uloric | 15 | $4,455 | $297 |
| Metoprolol | 136 | $4,439 | $33 |
| Hydralazine | 179 | $4,067 | $23 |
| Lisinopril | 441 | $3,717 | $8 |
| Spiriva | 12 | $3,370 | $281 |
| Amlodipine Besylate | 368 | $2,826 | $8 |
| Fenofibrate | 29 | $2,710 | $93 |
| Losartan | 159 | $2,286 | $14 |
| Labetalol | 38 | $2,115 | $56 |
| Furosemide | 319 | $1,479 | $5 |
| Valsartan-Hydrochlorothiazide | 13 | $1,171 | $90 |
| Minoxidil | 54 | $1,106 | $20 |
| Nifedipine Er | 15 | $906 | $60 |
| Simvastatin | 91 | $893 | $10 |
| Omeprazole | 74 | $882 | $12 |
| Potassium Chloride | 56 | $860 | $15 |
| Tamsulosin | 44 | $682 | $16 |
| Metoprolol | 84 | $658 | $8 |
| Clonidine | 72 | $634 | $9 |
| Carvedilol | 57 | $623 | $11 |
| Allopurinol | 101 | $611 | $6 |
| Klor-Con M20 | 37 | $599 | $16 |
| Hydrocodone-Acetaminophen | 37 | $575 | $16 |
| Amlodipine Besylate-Benazepril | 13 | $570 | $44 |
| Losartan-Hydrochlorothiazide | 21 | $565 | $27 |
| Pravastatin | 42 | $557 | $13 |
| Glipizide | 44 | $522 | $12 |
| Klor-Con 8 | 11 | $509 | $46 |
| Lidocaine-Prilocaine | 17 | $500 | $29 |
| Megestrol Acetate | 11 | $480 | $44 |
| Metolazone | 23 | $452 | $20 |
| Atenolol | 36 | $405 | $11 |
| Metformin | 51 | $383 | $8 |
| Bumetanide | 23 | $356 | $15 |
| Klor-Con 10 | 17 | $318 | $19 |
| Gemfibrozil | 15 | $295 | $20 |
| Benazepril | 29 | $283 | $10 |
| Hydrochlorothiazide | 41 | $274 | $7 |
| Isosorbide Mononitrate Er | 21 | $257 | $12 |
| Tramadol | 37 | $212 | $6 |
| Gabapentin | 22 | $192 | $9 |
| Levothyroxine | 14 | $161 | $12 |
| Cephalexin | 21 | $155 | $7 |
| Lisinopril-Hydrochlorothiazide | 13 | $152 | $12 |
| Metoclopramide | 22 | $107 | $5 |
| Temazepam | 24 | $102 | $4 |
| Glipizide Er | 11 | $78 | $7 |
| Ranitidine | 11 | $56 | $5 |
Money from drug and device companies
$493 in 2025
| 2025 | 12 | 21 | None | $493 |
| 2024 | 9 | 16 | None | $463 |
| 2023 | 5 | 5 | None | $150 |
| 2022 | 1 | 1 | None | $12 |
| 2021 | 1 | 5 | None | $190 |
| 2019 | 3 | 13 | None | $226 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Krystexxa | $99 | 4 payments
|
| Otsuka America Pharmaceutical | Jynarque | $97 | 4 payments
|
| Novo Nordisk | Wegovy | $57 | 2 payments
|
| Vifor Pharma | Veltassa | $48 | 2 payments
|
| Fresenius USA Marketing | Velphoro | $41 | 2 payments
|
| Mozarc Medical US | Palindrome | $33 | 1 payment
|
See all 21 published payments
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-15 | Jardiance | $23 |
| Otsuka America Pharmaceutical | Meals · 2025-12-08 | Jynarque | $23 |
| Travere Therapeutics | Meals · 2025-10-27 | None | $23 |
| Ardelyx | Meals · 2025-10-23 | Ibsrela | $15 |
| Novo Nordisk | Education · 2025-10-22 | Wegovy | $32 |
| Mozarc Medical US | Meals · 2025-09-15 | Palindrome | $33 |
| Novo Nordisk | Meals · 2025-09-04 | Rybelsus | $25 |
| Akebia Therapeutics | Meals · 2025-08-27 | Vafseo | $16 |
| Fresenius USA Marketing | Meals · 2025-08-07 | Velphoro | $24 |
| Apellis Pharmaceuticals | Meals · 2025-08-07 | Empaveli | $18 |
| Otsuka America Pharmaceutical | Meals · 2025-08-05 | Jynarque | $32 |
| Amgen | Meals · 2025-07-31 | Krystexxa | $27 |
| Mallinckrodt Hospital Products | Meals · 2025-07-22 | Acthar | $24 |
| Otsuka America Pharmaceutical | Meals · 2025-07-02 | Jynarque | $14 |
| Vifor Pharma | Meals · 2025-06-23 | Veltassa | $18 |
| Fresenius USA Marketing | Meals · 2025-06-11 | Velphoro | $16 |
| Amgen | Meals · 2025-05-29 | Krystexxa | $22 |
| Otsuka America Pharmaceutical | Meals · 2025-04-28 | Jynarque | $28 |
| Amgen | Meals · 2025-04-16 | Krystexxa | $20 |
| Vifor Pharma | Meals · 2025-03-19 | Veltassa | $30 |
| Amgen | Meals · 2025-01-08 | Krystexxa | $29 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $463
| Boston Scientific | Axios | $109 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $82 | 3 payments
|
| Fresenius USA Marketing | Velphoro | $71 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $49 | 2 payments
|
| Amgen | Krystexxa | $42 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $33 | 2 payments
|
| Novo Nordisk | Ozempic | $32 | 1 payment
|
| Kyowa Kirin | Crysvita | $29 | 1 payment
|
| Lilly USA | Jardiance | $16 | 1 payment
|
2023: $150
| Amgen | Tavneos | $67 | 1 payment
|
| Horizon Therapeutics plc | None | $26 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $23 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $19 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $15 | 1 payment
|
2022: $12
| Vifor Pharma | None | $12 | 1 payment
|
2021: $190
| AstraZeneca Pharmaceuticals LP | Lokelma | $190 | 3 payments
|
2019: $226
| Akebia Therapeutics | Auryxia | $94 | 11 payments
|
| Abbott Laboratories | Cardiomems Hf System | $71 | 1 payment
|
| Otsuka America Pharmaceutical | Samsca | $61 | 1 payment
|
Professional record
- NPI
- 1083611594
- Licence
- CA A104576California A104576: Current · expires 2028-01-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- AZ 216932, OH 2483987
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 1805 N California St, Ste 303, Stockton, CA, 95204
- NPI first listed
- 2005-06-30
- NPI last updated
- 2023-08-07
- NPI record certified
- 2023-08-07
This is when the NPI record was last certified, not a medical board exam.